Literature DB >> 18355776

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.

Robert P Kauffman1, Teresa E Baker, Vicki M Baker, Pamela DiMarino, V Daniel Castracane.   

Abstract

OBJECTIVE: The Rotterdam criteria extend the phenotypic spectrum of polycystic ovary syndrome (PCOS). We characterized endocrine and metabolic differences among women meeting the National Institutes of Health (NIH) definition for PCOS vs two novel phenotypes established by the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine definition. STUDY
DESIGN: Endocrine and metabolic data from a retrospective analysis of 160 age- and weight-matched women with PCOS and 23 controls were compared. Insulin sensitivity indices were correlated with androgens, gonadotropins, and lipids within each phenotype.
RESULTS: Ovarian and adrenal androgens were highest in the NIH-defined PCOS group, lowest in the nonhyperandrogenic PCOS group, and intermediate in the hyperandrogenic ovulatory PCOS population. Insulin sensitivity indices, gonadotropins, and lipids were similar across all PCOS phenotypes. The magnitude of insulin resistance correlated with free testosterone only in the NIH-defined group.
CONCLUSION: Androgen levels are the major distinguishing endocrine feature differentiating phenotypic expressions of PCOS. Hyperinsulinemia correlates with free testosterone levels only in traditional NIH-defined women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355776     DOI: 10.1016/j.ajog.2008.01.037

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Predictors of Depression in Iranian Women with Polycystic Ovarian Syndrome.

Authors:  Mojgan Mirghafourvand; Sakineh Mohammad-Alizadeh Charandabi; Tahereh Behroozi Lak; Fatemeh Aliasghari
Journal:  Community Ment Health J       Date:  2017-11-14

2.  Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome.

Authors:  Mahnaz Ashrafi; Fatemeh Sheikhan; Arezoo Arabipoor; Nicole Rouhana; Roya Hosseini; Zahra Zolfaghari
Journal:  Oman Med J       Date:  2017-05

3.  Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome.

Authors:  Mohadetheh Moulana
Journal:  Life Sci       Date:  2019-01-29       Impact factor: 5.037

4.  Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.

Authors:  Marla E Lujan; Terri G Bloski; Donna R Chizen; Denis C Lehotay; Roger A Pierson
Journal:  Hum Reprod       Date:  2009-10-24       Impact factor: 6.918

5.  The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.

Authors:  Fahimeh Ramezani Tehrani; Masoumeh Simbar; Maryam Tohidi; Farhad Hosseinpanah; Fereidoun Azizi
Journal:  Reprod Biol Endocrinol       Date:  2011-03-25       Impact factor: 5.211

6.  The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.

Authors:  Ferdous Mehrabian; Behnaz Khani; Roya Kelishadi; Narges Kermani
Journal:  J Res Med Sci       Date:  2011-06       Impact factor: 1.852

7.  Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome?

Authors:  Marià Alemany
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

8.  Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS.

Authors:  Kim Forrester-Dumont; Ovidiu Galescu; Andrey Kolesnikov; Nouhad Raissouni; Amrit Bhangoo; Svetlana Ten; Amy Suss
Journal:  Int J Endocrinol       Date:  2012-03-27       Impact factor: 3.257

9.  Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).

Authors:  Susanne Tan; André Scherag; Onno Eilard Janssen; Susanne Hahn; Harald Lahner; Tiina Dietz; Susann Scherag; Harald Grallert; Carla Ivane Ganz Vogel; Rainer Kimmig; Thomas Illig; Klaus Mann; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2010-01-21       Impact factor: 2.103

10.  Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome.

Authors:  Nese Cinar; Ayla Harmanci; Duygu Yazgan Aksoy; Kadriye Aydin; Bulent Okan Yildiz
Journal:  J Ovarian Res       Date:  2012-12-07       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.